Covid-19 roundup: In­vestors call to link CEO salaries to vac­cine ac­cess; Why there aren't more ini­tial sup­plies of the Pfiz­er pill

A group of in­sti­tu­tion­al in­vestors from No­mu­ra, BMO, GAM and more than 60 oth­ers rep­re­sent­ing tril­lions in as­sets are now call­ing on Covid-19 vac­cine de­vel­op­ers to link their ex­ec­u­tives’ pay to en­sure the vac­cines are avail­able glob­al­ly.

“It is clear that cur­rent­ly a large part of the world pop­u­la­tion still does not have suf­fi­cient and eq­ui­table ac­cess to vac­cines,” the in­vestors said in ex­plain­ing their rea­son­ing be­hind Thurs­day’s let­ter to the ex­ecs at Pfiz­er, Mod­er­na, As­traZeneca and J&J.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER